Aeluma intends to offer and sell shares of its stock in a public offering. The stock fell 9% to $15.49 after the bell Wednesday.
Arvinas said it was cutting 15% of its workforce as it plans to outsource the licensing for the commercialization of its breast cancer treatment vepdegestrant. Shares declined 3% to $7.40 in after-hours trading.
Red Cat also announced a share offering of its common stock. Shares fell 7% to $10.47.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
September 17, 2025 19:55 ET (23:55 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.